| | | Single nucleotide variant (missense variant +1 more) | Epilepsy, idiopathic generalized, susceptibility to, 9 | |
| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 9 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Epilepsy, idiopathic generalized, susceptibility to, 9 | |
| | | Single nucleotide variant (intron variant) | Epilepsy, idiopathic generalized, susceptibility to, 9 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Idiopathic generalized epilepsy +2 more | |
| | | Single nucleotide variant (missense variant) | Episodic ataxia type 5 +4 more | |
| | | Single nucleotide variant (missense variant) | Epilepsy, idiopathic generalized, susceptibility to, 9 +2 more | |
| | | Deletion (frameshift variant +1 more) | Epilepsy, idiopathic generalized, susceptibility to, 9 | |
| | CACNB4, LOC129934925 (P15R) | Single nucleotide variant (missense variant) | CACNB4-related condition +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Idiopathic generalized epilepsy +1 more | GConflicting classifications of pathogenicity |
| | CACNB4, LOC129934925 (S2F) | Single nucleotide variant (missense variant) | CACNB4-related condition +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | CACNB4-related condition +4 more | GConflicting classifications of pathogenicity |